This review was written by three authors, independent from us. They describe the latest advances with CRP targeting strategies including the therapeutic reduction of circulating CRP levels. The therapeutic potential to mitigate the harmful effects that CRP is associated with, is being discussed.

The whole publication: C-reactive protein: a target for therapy to reduce inflammation can be found here.